Patent · US Active

Modular nanoparticles for adaptable vaccines

US8889117B2 · kind B2 · utility

14Cited by
2References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 15, 2008
Grant dateNov 18, 2014
Priority date
Expiry dateMay 24, 2028

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB82Y5/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Modular nanoparticle vaccine compositions and methods of making and using the same have been developed. Modular nanoparticle vaccine compositions comprise an antigen encapsulated in a polymeric particle and adaptor elements which modularly couple functional elements to the particle. The modular design of these vaccine compositions, which involves flexible addition and subtraction of antigen, adjuvant, immune potentiators, molecular recognition and transport mediation elements, as well as intracellular uptake mediators, allows for exquisite control over variables that are important in optimizing an effective vaccine delivery system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.